Hepatitis is an inflammation of the liver, most commonly caused by a viral infection. There are five main hepatitis viruses that cause acute and/or chronic infection, referred to as types A, B, C, D and E. In particular, types B and C lead to chronic disease in hundreds of millions of people worldwide. In the WHO European Region an estimated 15 million people live with chronic hepatitis B, and an estimated 14 million people are infected with hepatitis C. Because the disease is often asymptomatic and left untreated, chronic hepatitis is a major cause of liver cirrhosis and primary liver cancer. People who inject drugs are particularly vulnerable to hepatitis and co-infection with both hepatitis and HIV is common.
Top storyFirst Regional Consultation on Viral Hepatitis in Europe shows progress and reaffirms countries’ commitment to elimination
The First Regional Consultation on Viral Hepatitis in the WHO European Region is a landmark on the road to eliminating the disease by 2030. Viral hepatitis is a public health threat affecting tens of millions of people in the Region. One hundred and twenty participants from 45 Member States convened in Tbilisi, Georgia, on 11–13 February 2019 to discuss all aspects of the response and exchange tools and experiences to address common challenges.
- Call for applications: experts in HIV and/or hepatitis sought to join ELI core group for 2019–2020
- Call for good practices of intersectoral collaboration to end HIV, tuberculosis and viral hepatitis
- Day 4 highlights: Regional Director thanks “the strongest minds and warmest hearts in public health”
PublicationsGuidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection (2018) More publications
InfographicMore data and statistics
Prevent hepatitis. Act now.
WHO Regional Office for Europe works with several key partners on activities related to hepatitisRead more